Do Traders Think Immatics NV (IMTX) Can Turn Around Friday?

The market has been down on Immatics NV (IMTX) stock recently. IMTX gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Immatics NV has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on IMTX!

See Full IMTX Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With IMTX Stock Today?

Immatics NV (IMTX) stock is trading at $11.23 as of 11:58 AM on Friday, Sep 29, an increase of $0.22, or 2% from the previous closing price of $11.01. The stock has traded between $11.02 and $11.50 so far today. Volume today is less active than usual. So far 82,568 shares have traded compared to average volume of 314,742 shares.

More About Immatics NV

Immatics NV is engaged in the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's pipeline consists of two lead product classes, engineered Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics (TCER). Each therapeutic modality has distinct attributes to produce the desired therapeutic effect for patients at different disease stages and with different types of tumors focusing on particularly hard-to-treat solid cancers. Click Here to get the full Stock Report for Immatics NV stock.